What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences.

Eleni Rebelos Ioanna A AnastasiouAnastasios TentolourisNikoloas Papanas Edward B Jude

Published in: The international journal of lower extremity wounds (2024)

Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic.

Keyphrases

type diabetes
cardiovascular disease
glycemic control
end stage renal disease
chronic kidney disease
ejection fraction
current status
metabolic syndrome
insulin resistance
skeletal muscle
adipose tissue
patient reported outcomes
case control
replacement therapy